CYTOTOXICITY IDENTIFICATION OF THE SUPERNATANT OF Manihot esculenta Crantz RHIZOME AS RIBOSOME-INACTIVATING PROTEIN TO NORMAL CELL

https://doi.org/10.22146/ijc.21857

Endang Astuti(1*), Sabirin Matsjeh(2), Winarto Haryadi(3), Deni Pranowo(4), Nuning Sri Mulatsih(5)

(1) Chemistry Department, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta
(2) Chemistry Department, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta
(3) Chemistry Department, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta
(4) Chemistry Department, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta
(5) Chemistry Department, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta
(*) Corresponding Author

Abstract


The supernatant of Manihot esculenta Crantz rhizome has been used as an alternative remedy of infectious and cancer in Jogjakarta. Cytotoxicity assay showed that  Manihot esculenta Crantz supernatant had cytotoxic effect to cancer cell line, namely Myeloma (LC50 = 180,24 μg/mL) and HeLa (LC50 = 415,55 μg/mL), but have a little cytotoxic effect to SiHa. This research was aimed to identify cytotoxic activity of Manihot esculenta Crantz's supernatant to normal cell, particularly to human mononuclear cell and Vero cell line, and to compare to the cancer cell lines. The result showed that supernatant of M. esculenta had cytotoxic effect to normal mononuclear cell (LC50 = 564,00 μg/mL) and Vero cell line (LC50 = 686,00 μg/mL). The supernatant of M. esculenta had the highest cytotoxic activity to myeloma and relatively toxic to cervix cancer HeLa and normal cell, but less to SiHa.


Keywords


Manihot esculenta Crantz; Ribosome-inactivating Protein (RIP); cytotoxic; normal cell; cancer cell

Full Text:

Full Text Pdf


References

[1] Haryana, S.M., 1999, Pemeriksaan Sitogenik, Biologi Molekuler dan Imunologi Sebagai Sarana Deteksi Dini dan Kriteria Faktor Prognostik Mutakhir Penderita Kanker, Prosiding Seminar Teknologi Kedokteran, FK-UGM, Jogjakarta

[2] Pharmd, S.D.U, 2002, Anticancer Drugs, HealthAtoz.com

[3] Barbieri, L., Batteli, M.G., and Stirpe, F., 1993, Biochem. Et Biophys. Acta, 10, 405-410, 1154, 237-271

[4] LaCasse, E.C., Bray, M.R., Patterson, B., Lim, W.M., and Perampalan, S., 1999, Blood, 94, 2901-2910

[5] Ferens, W.A., and Hovde, C.J., 2000, Infection and Immunity, 68, 4462-4469

[6] Lee-Huang, S., Kung, H., and Huang, P.L, 1994, Proc. Natl. Acad. Sci. USA, 91, 12208-12212

[7] Au, T.K., Collins, R.A., and Lam, T.L., 2000, FEBS Lett, 471, 169-172

[8] Astuti, E., Matsjeh, S., Haryadi, W., Pranowo, D., Puspita, R., Khasanah, L., dan Yuliana, R., 2003, Selektivitas Sitotoksik Supernatan Umbi Manihot Esculenta Crantz Dengan Aktivitas Ribosome-Inactivating Protein Terhadap Myeloma, HeLa Dan Siha Cell Lines, Prosiding Seminar Nasional Kimia XII, Jogjakarta

[9] Anonim, 2003, Vero http : //Square. Umin.Ac.JP/miura/Cell.Div./vero/, diakses pada tanggal 15 Mei 2003

[10] Mosmann, T., 1983, J. Immunological Methods, 65, 55-63

[11] Tada, H., Shiho, O., Kuroshima, K., Koyama, M., and Tsukamoto, K., 1986, An Improved Colorimetric Assay for Interleukin 2, J. Immuno-logical Methods, 93, 157-166

[12]Li, M.X., Yeung, H.W, and Pan, L.P., 1991, Nucleic Acid Res., 19, 6309-6312



DOI: https://doi.org/10.22146/ijc.21857

Article Metrics

Abstract views : 1313 | views : 1036


Copyright (c) 2010 Indonesian Journal of Chemistry

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

 

Indonesian Journal of Chemistry (ISSN 1411-9420 /e-ISSN 2460-1578) - Chemistry Department, Universitas Gadjah Mada, Indonesia.

Web Analytics View The Statistics of Indones. J. Chem.